I notice we have a couple of helpfuls giving us shareholderssome sage advice about our investments. Cleverly disguised as intelligent and knowledgeableinvestors, not being outwardly negative, just looking through a negative lense at the obstacles that Imugene might encounter in the road ahead. Shareholders should be looking to credible sources ofinformation, those being actual results and announcements from the companyitself. We all know, or should know the risks involved in ourpersonal investments and the company’s disclosures also offer a dose of what couldgo wrong. If after taking account of the risks and tying these to yourown risk profile as we all should, and we decide to stick this out then these “helpfulanonymous posters”, can largely be ignored. Some of our more impressive posters can at times be taken inby the above-mentioned intellect, I prefer to look at actions of people ratherthan their words for example those posting 15-20 posts per day is a realwarning sign for me. I have mentioned in previous posts that I am terrible atmaking predictions, and I take with a grain of salt the predictions of others,we do know further updates are expected not far away (3-6 months), and thepotential for Fast Track and Orphan Drug Designation should data support these.
DYOR opinion only
IMU Price at posting:
4.3¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)